Correction: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer

Br J Cancer. 2024 Mar;130(5):892. doi: 10.1038/s41416-024-02606-w.
No abstract available

Publication types

  • Published Erratum